Global Financial Private Client, LLC Gilead Sciences, Inc. Transaction History
Global Financial Private Client, LLC
- $262 Billion
- Q1 2025
A detailed history of Global Financial Private Client, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 7,521 shares of GILD stock, worth $822,270. This represents 0.32% of its overall portfolio holdings.
Number of Shares
7,521
Previous 6,068
23.95%
Holding current value
$822,270
Previous $561 Million
50.35%
% of portfolio
0.32%
Previous 0.21%
Shares
15 transactions
Others Institutions Holding GILD
# of Institutions
2,287Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.8 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.51 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.97 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.85 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $137B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...